American Journal of Respiratory and Critical Care Medicine

Diseases, Conditions, Syndromes

Study finds key regulator in pulmonary fibrosis

A Yale-led research team has identified an important enzyme that could lead to new therapies for a chronic fatal lung disease that affects hundreds of thousands in the United States each year.

Health

Five-year mortality, costs up for ICU survivors

(HealthDay)—Intensive care unit (ICU) patients surviving to hospital discharge have higher five-year mortality and hospital resource use than hospital controls, according to a study published online Jan. 27 in the American ...

Cardiology

24/7 intensivist in pediatric ICU improves patient outcomes

(HealthDay)—Having a 24/7 intensivist in pediatric intensive care units (ICUs) is associated with improved patient outcomes, according to a study published in the Dec. 15 issue of the American Journal of Respiratory and ...

Diseases, Conditions, Syndromes

ATS issues conditional guidance for persistent infantile wheezing

(HealthDay)—A committee sanctioned by the American Thoracic Society has developed conditional guidelines for the diagnostic evaluation of infants with recurrent or persistent wheezing, but more research is needed. The guidelines ...

Health

When it comes to respiratory effects of wood smoke, sex matters

Exposure to wood smoke can have different effects on the respiratory immune systems of men and women—effects that may be obscured when data from men and women are lumped together, according to a study published today in ...

Surgery

Six-minute walk distance IDs post-lung transplant survival

(HealthDay)—For patients undergoing lung transplantation, six-minute walk distance (6MWD) predicts postoperative survival, according to a study published online June 11 in the American Journal of Respiratory and Critical ...

page 30 from 40